应用两种方法来检测由于时间变化的变量而导致的未测量的混,在自我控制的风险间隔设计中评估COVID-19疫苗安全信号,使用心肌炎作为案例例
Sophie H Bots1, Svetlana Belitser1, Rolf H H Groenwold2
1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB, Utrecht, The Netherlands.
American journal of epidemiology
|July 3, 2024
概括
自控风险间隔 (SCRI) 设计对于COVID-19疫苗安全性研究是强大的,即使有时间变化的混因素. 定量偏差分析和负对照结果证实了它对评估心肌炎风险的可靠性.
科学领域:
- 药学流行病学 药学流行病学
- 疫苗安全研究 疫苗安全研究
- 生物统计学 生物统计学
背景情况:
- 时间变化的混在疫苗安全研究中带来了挑战.
- 自控风险间隔 (SCRI) 设计是解决这些挑战的潜在方法.
- 对研究设计进行强有力的验证对于可靠的安全信号检测至关重要.
研究的目的:
- 评估自控风险区间 (SCRI) 设计的稳定性.
- 在因COVID-19疫苗接种而导致的时间变化混的背景下评估SCRI设计.
- 检查COVID-19疫苗接种后肌心炎风险估计中的潜在偏差.
主要方法:
- 使用了5个欧洲数据库,包括从2020年9月起接种疫苗的病例.
- 使用SCRI设计,60天的控制窗口和剂量特定的28天的风险窗口.
- 纳入负控制结果 (外耳炎) 和定量偏差分析 (QBA) 来评估混.
主要成果:
- 负对照结果 (外耳炎) 与COVID-19疫苗的相关性很小.
- 定量偏差分析表明,即使是像COVID-19感染这样的强烈混因素也不能完全解释观察到的肌心炎风险.
- 该SCRI设计证明了对未测量的混的稳定性,具有有限的上升偏差的潜力.
结论:
- 自主控制风险间隔 (SCRI) 设计对于评估COVID-19疫苗安全性,包括心肌炎风险,似乎很强大.
- 虽然一般可靠,但未测量混偏差结果的可能性值得考虑.
- 建议对不同的安全信号进行进一步复制,以加强对SCRI方法的信心.
更多相关视频
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Confounding in Epidemiological Studies
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...


